Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

CKD-4.1 Data Details

Expand All

CKD-4.1 Increase the proportion of persons with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and microalbuminuria

About the Data: National

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Data Source: 
United States Renal Data System
Changed Since the Healthy People 2020 Launch: 
Yes
Measure: 
percent
Baseline (Year): 
25.8 (2007)
Target: 
28.4
Target-Setting Method: 
10 percent improvement
Numerator: 

Number of persons aged 65 years and over with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and microalbumin tests

Denominator: 

Number of persons aged 65 years and over with chronic kidney disease

Comparable Healthy People 2010 Objective: 
Adapted from HP2010 objective
Methodology Notes: 

    The data to track this objective come from the United States Renal Data System (USRDS) 5% Medicare sample. Proper wording is microalbumin testing instead of microalbuminuria. The USRDS data, data collection procedures, calculation methods, and other technical information are included in the USRDS Annual Data Report.

Changes Between HP2010 and HP2020: 
This objective differs from Healthy People 2010 objective 4-8a which measured medical evaluation among persons aged 65 years and over with diabetes and chronic kidney disease (CKD). This objective tracks medical evaluation among all persons with CKD. The recommendations for medical evaluation of persons with CKD have been updated and currently include serum creatinine, lipids, and microalbumin tests. Consequently, data for this objective are not comparable with data for the Healthy People 2010 objective.

About the Data: State

Description of the data source, numerator, denominator, survey questions, and other relevant details about the state-level data.

Data Source: 
United States Renal Data System
Measure: 
percent
Numerator: 

Number of persons aged 65 years and over with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and microalbumin tests

Denominator: 

Number of persons aged 65 years and over with chronic kidney disease

Methodology Notes: 

      The data to track this objective come from the United States Renal Data System (USRDS) 5% Medicare sample. Proper wording is microalbumin testing instead of microalbuminuria. The USRDS data, data collection procedures, calculation methods, and other technical information are included in the USRDS Annual Data Report.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch: 
In 2018, the original baseline was revised from 25.9 to 25.8 percent due to USRDS rates re-estimation. There is some lag in reporting new cases of ESRD. Therefore, each year’s Annual Data Report includes re-estimates of earlier year rates. For more information see the USRDS Annual Data Reports. The target was adjusted from 28.5 to 28.4 percent to reflect the revised baseline using the original target-setting method.

References

Additional resources about the objective

  1. U.S. Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012